Treatment of patients with alcoholic liver disease
Treatment of patients with alcoholic liver disease
参考文献45
-
1庄辉,张华捷.酒精性肝病的流行病学[J].胃肠病学,2003,8(5):294-297. 被引量:11
-
2Kester I. Crosse MD,Frank A. Anania MD, FACP.Alcoholic hepatitis[J]. Current Treatment Options in Gastroenterology . 2002 (6)
-
3Stéphane Lévy,Christian Hervé,Edouard Delacoux,Serge Erlinger.Thiamine Deficiency in Hepatitis C Virus and Alcohol-Related Liver Diseases[J]. Digestive Diseases and Sciences . 2002 (3)
-
4Pessione F,,Ramond MJ,Peters L,Pham BN,Batel P,Rueff B, et al.Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepati- tis, smoking and abstinence. Liver International . 2003
-
5Mendenhall CL,Tosch T,Weesner RE,Garcia-Pont P,Goldberg SJ,Kiernan T, et al.VA cooperative study on alco- holic hepatitis. Prognostic significance of protein-calorie malnutrition. The American Journal of Clinical Nutrition . 1986
-
6Crosse KI,Anania FA.Alcoholic hepatitis. Current Treatment Options in Gastroenterology . 2002
-
7Bergheim I,Parlesak A,Dierks C,Bode JC,Bode C.Nutri- tional deficiencies in German middle-class male alcohol consum- ers; relation to dietary intake and severity of liver disease. European Journal of Clinical Nutrition . 2003
-
8Ronis MJ,Korourian S,Zipperman M,Hakkak R,Badger TM.Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composi- tion. The Journal of Nutrition . 2004
-
9Cabré E,Rodríguez-Iglesias MP,Caballeria J,Quer JC,JL,Parés A, et al.Short-and long-term outcome of severe alcohol-induced hepatitis treated with ste- roids or enteral nutrition: a multicenter randomized trial. He- patology . 2000
-
10Mathurin P,Mendenhall CL,Carithers RL Jr,Ramond MJ,Maddrey WC,Garstide P, et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis(AH) : individual data analysis of the last three randomized pla- cebo controlled double blind trials of corticosteroids in severe al- coholic hepatitis. Journal of Hepatology . 2002
二级参考文献7
-
1Harriet Gordon.Detection of alcoholic liver disease[J].World Journal of Gastroenterology,2001,7(3):297-302. 被引量:13
-
2王辉,王江滨.肝炎病毒感染与酒精性肝硬化关系的研究(附182例酒精性肝病临床病例报告)[J].白求恩医科大学学报,1998,24(6):652-653. 被引量:45
-
3王宝恩,尹珊珊.酒精性肝病的流行病学[J].中华肝脏病杂志,2001,9(5):312-312. 被引量:65
-
4凌奇荷,卿笃信.重视对酒精性肝病的研究[J].中华消化杂志,2001,21(9):517-518. 被引量:17
-
5厉有名.第一讲 酒精性肝病的分类及其诊断标准若干问题[J].中华消化杂志,2002,22(1):38-39. 被引量:61
-
6鲁晓岚,陶明,罗金燕,耿燕,赵红莉,赵平.饮酒与肝病流行病学调查[J].中华肝脏病杂志,2002,10(6):467-468. 被引量:96
-
7中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):72-72. 被引量:585
共引文献17
-
1Radan Bruha,Karel Dvorak,Jaromir Petrty.Alcoholic liver disease[J].World Journal of Hepatology,2012,4(3):81-90. 被引量:29
-
2Hetal A Karsan,Samir Parekh.Management of alcoholic hepatitis:Current concepts[J].World Journal of Hepatology,2012,4(12):335-341. 被引量:6
-
3Sarat C Jampana,Rashid Khan.Pathogenesis of alcoholic hepatitis:Role of inflammatory signaling and oxidative stress[J].World Journal of Hepatology,2011,3(5):114-117. 被引量:2
-
4Ashwani K Singal,Ishmeet Walia,Anjna Singal,Roger D Soloway.Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis:Current status[J].World Journal of Hepatology,2011,3(8):205-210. 被引量:7
-
5Gabriel L Reep,Roger D Soloway.Recent and currently emerging medical treatment options for the treatment of alcoholic hepatitis[J].World Journal of Hepatology,2011,3(8):211-214. 被引量:2
-
6Fei Wang and Bing-Yuan Wang Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang 110001, China.Corticosteroids or non-corticosteroids: a fresh perspective on alcoholic hepatitis treatment[J].Hepatobiliary & Pancreatic Diseases International,2011,10(5):458-464. 被引量:8
-
7刘畅,王炳元.酒精性肝炎治疗方法的评价[J].药品评价,2007,4(2):101-104. 被引量:3
-
8陈小桃.还原型谷胱甘肽和维生素E预防酒精性肝病的临床研究[J].国际医药卫生导报,2007,13(12):42-44.
-
9付强强,曾涛,李阳,闫捷,张翠丽,谢克勤.大蒜油治疗小鼠酒精性脂肪肝的研究[J].毒理学杂志,2010,24(5):392-395. 被引量:7
-
10俞宏斌,朱炜,戴闯,冯文明.余甘子对大鼠酒精性脂肪肝的炎症抑制作用研究[J].中国现代医生,2012,50(4):9-11. 被引量:9
-
1李昱江,诸葛宇征.S-腺苷蛋氨酸在肝脏疾病发生发展中作用的研究进展[J].东南大学学报(医学版),2012,31(5):661-664. 被引量:12
-
2赵天仪,李益明.丙硫氧嘧啶诱发抗中性粒细胞胞质抗体相关性血管炎患者Graves病治疗策略[J].药物不良反应杂志,2015,17(2):99-100. 被引量:7
-
3赖亚新,单忠艳.抗甲状腺药物的不良反应[J].中华全科医师杂志,2008,7(3):151-153. 被引量:1
-
4王瑞英,常湛,李娟,王倩,张松筠.MCP-1在甲状腺功能减退症大鼠肾脏中的表达及与甲状腺功能的关系[J].河北医科大学学报,2010,31(9):1033-1037. 被引量:1
-
5陈永熙,陈楠.丙硫氧嘧啶诱发抗中性粒细胞胞质抗体相关性血管炎特点[J].药物不良反应杂志,2015,17(2):93-94. 被引量:1
-
6查金顺,林玲,周明宣,蒋艳.^131I治疗丙基硫氧嘧啶致Graves病ANCA相关性血管炎二例[J].中华核医学杂志,2011,31(3):210-211. 被引量:2
-
7林玲,陈小青.聚焦丙硫氧嘧啶安全性--弥漫性肺泡出血[J].药物不良反应杂志,2015,17(2):90-93.
-
8Cui HF,Jiang XL.Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin[J].World Journal of Gastroenterology,1999,5(5):448-450. 被引量:24
-
9吴朝明,顾雪疆,应斌宇.丙硫氧嘧啶致严重肝损害及粒细胞减少症1例[J].新医学,2005,36(3):129-129.
-
10罗秀员.氯雷他定治疗小儿过敏性咳嗽的临床观察[J].健康研究,2015,35(3):328-329. 被引量:4